Prognosis
Pfizer Kids Shot Backed by FDA Panel; Africa Doses: Virus Update
This article is for subscribers only.
The Pfizer Inc.-BioNTech SE shot for children as young as 5 won the backing of the U.S. Food and Drug Administration’s vaccines advisory committee. The agency isn’t required to follow the panel’s recommendations, but it often does.
Hospital admissions are declining sharply among U.S. children with Covid-19, even more than adults, quieting concerns for now that the return to school could trigger a major uptick in viral transmission.